Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Şükriye Öner"'
BACKGROUND The antifibrotic drugs nintedanib and pirfenidone reduce disease progression in idiopathic pulmonary fibrosis (IPF) and have also shown to improve survival. Switching first-line antifibrotic drug may required in IPF due to disease progress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74c77e1fb45c71935076a94b688dae7b
https://avesis.deu.edu.tr/publication/details/51bf80d5-db06-4ab5-bf67-d2d086367c02/oai
https://avesis.deu.edu.tr/publication/details/51bf80d5-db06-4ab5-bf67-d2d086367c02/oai
